Literature DB >> 26577160

Theoretical cross-comparative analysis on dynamics of small intestine and colon crypts during cancer initiation.

Irina A Roznovăţ1, Heather J Ruskin2.   

Abstract

Epigenetics is emerging as a fundamentally important area of biological and medical research that has implications for our understanding of human diseases including cancer, autoimmune and neuropsychiatric disorders. In the context of recent efforts on personalised medicine, a novel research direction is concerned with identification of intra-individual epigenetic variation linked to disease predisposition and development, i.e. epigenome-wide association studies. A computational model has been developed to describe the dynamics and structure of human intestinal crypts and to perform a comparative analysis on aberrant DNA methylation level induced in these during cancer initiation. The crypt framework, AgentCrypt, is an agent-based model of crypt dynamics, which handles intra- and inter-dependencies. In addition, the AgentCrypt model is used to investigate the effect of a set of potential inhibitors with respect to methylation modification in intestinal tissue during initiation of disease. Methylation level decrease over a relatively short period of 90 days is marked for the colon compared to the small intestine, although similar alterations are induced in both tissues. In addition, inhibitor effect is notable for abnormal crypt groups, with largest average methylation differences observed ≈0.75% lower in the colon and ≈0.79% lower in the small intestine with inhibitor present.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26577160      PMCID: PMC8687420          DOI: 10.1049/iet-syb.2015.0048

Source DB:  PubMed          Journal:  IET Syst Biol        ISSN: 1751-8849            Impact factor:   1.615


  42 in total

Review 1.  Stem cell in gastrointestinal structure and neoplastic development.

Authors:  M Brittan; N A Wright
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

Review 2.  A review of spatial computational models for multi-cellular systems, with regard to intestinal crypts and colorectal cancer development.

Authors:  Giovanni De Matteis; Alex Graudenzi; Marco Antoniotti
Journal:  J Math Biol       Date:  2012-05-08       Impact factor: 2.259

Review 3.  From promises to practical strategies in epigenetic epidemiology.

Authors:  Jonathan Mill; Bastiaan T Heijmans
Journal:  Nat Rev Genet       Date:  2013-07-02       Impact factor: 53.242

Review 4.  Epigenome-wide association studies for common human diseases.

Authors:  Vardhman K Rakyan; Thomas A Down; David J Balding; Stephan Beck
Journal:  Nat Rev Genet       Date:  2011-07-12       Impact factor: 53.242

5.  Rule-Based Simulation of Multi-Cellular Biological Systems-A Review of Modeling Techniques.

Authors:  Minki Hwang; Marc Garbey; Scott A Berceli; Roger Tran-Son-Tay
Journal:  Cell Mol Bioeng       Date:  2009-09       Impact factor: 2.321

Review 6.  Colorectal cancer stem cells.

Authors:  Aristides G Vaiopoulos; Ioannis D Kostakis; Michael Koutsilieris; Athanasios G Papavassiliou
Journal:  Stem Cells       Date:  2012-03       Impact factor: 6.277

Review 7.  The fundamental role of epigenetic events in cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Nat Rev Genet       Date:  2002-06       Impact factor: 53.242

Review 8.  Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies.

Authors:  Rocio G Urdinguio; Jose V Sanchez-Mut; Manel Esteller
Journal:  Lancet Neurol       Date:  2009-11       Impact factor: 44.182

9.  Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips.

Authors:  Vladimir A Naumov; Edward V Generozov; Natalya B Zaharjevskaya; Darya S Matushkina; Andrey K Larin; Stanislav V Chernyshov; Mikhail V Alekseev; Yuri A Shelygin; Vadim M Govorun
Journal:  Epigenetics       Date:  2013-07-17       Impact factor: 4.528

10.  Cancer epigenetics: new therapies and new challenges.

Authors:  Eleftheria Hatzimichael; Tim Crook
Journal:  J Drug Deliv       Date:  2013-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.